FTH insider transaction filings
Faeth Therapeutics, Inc. — 11 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-15. Screen FTH transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 7 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 23 legs across 4 filings by 2 insiders — 49,494 shares, $1,188,763 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 6,836 shares @ $24.12 ($164,884) by STEPHENSON BRIAN C, filed 2026-06-24.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| STEPHENSON BRIAN C — Chief Financial Officer | 3 | 22 legs · 46,688 sh · $1,133,317 | — | — |
| Parikh Anand Kiran — President and CEO, Director | 2 | 1 leg · 2,806 sh · $55,447 | — | 5 |
| Craver Josiah — PAO | 1 | — | — | 1 |
| Vousden Karen H — Director | 1 | — | — | 1 |
Recent Form 4 filings — Faeth Therapeutics, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-15 | 4 | Vousden Karen H — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | Parikh Anand Kiran — President and CEO, Director | Grant/award (A): 398,018 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | Craver Josiah — PAO | Grant/award (A): 30,824 (derivative) @ $0 | EDGAR |
| 2026-07-01 | 4 | STEPHENSON BRIAN C — Chief Financial Officer | Purchase (P): 831 @ $23.34 · Purchase (P): 1,910 @ $22.95 · Purchase (P): 1,638 @ $23.88 · Purchase (P): 4,255 @ $24.98 · Purchase (P): 4,400 @ $23.40 · Purchase (P): 600 @ $24.22 | EDGAR |
| 2026-06-26 | 4 | STEPHENSON BRIAN C — Chief Financial Officer | Purchase (P): 2,891 @ $25.22 · Purchase (P): 3,000 @ $25.98 · Purchase (P): 3,400 @ $26.98 · Purchase (P): 100 @ $27.77 · Purchase (P): 580 @ $23.61 · Purchase (P): 4,212 @ $24.90 · +2 more | EDGAR |
| 2026-06-24 | 4 | Parikh Anand Kiran — President and CEO, Director | Purchase (P): 2,806 @ $19.76 · Option exercise (M): 45,252 @ $1.16 · Option exercise (M): 8,213 @ $1.16 · Option exercise (M): 45,252 (derivative) @ $0 · Option exercise (M): 8,213 (derivative) @ $0 | EDGAR |
| 2026-06-24 | 4 | STEPHENSON BRIAN C — Chief Financial Officer | Purchase (P): 1,797 @ $20.23 · Purchase (P): 1,118 @ $20.82 · Purchase (P): 1,583 @ $22.40 · Purchase (P): 3,329 @ $23.28 · Purchase (P): 356 @ $23.95 · Purchase (P): 6,836 @ $24.12 · +2 more | EDGAR |
| 2026-06-16 | 4 | Hahn Stephen M. — Director | Conversion (C): 44,763 · Grant/award (A): 25,000 (derivative) @ $0 · Conversion (C): 44.76 (derivative) | EDGAR |
| 2026-06-16 | 4 | Parikh Anand Kiran — President and CEO, Director | Conversion (C): 761,428 · Conversion (C): 761.43 (derivative) | EDGAR |
| 2026-06-16 | 4/A | Parikh Anand Kiran — President and CEO, Director | Grant/award (A): 761.43 (derivative) · Grant/award (A): 12,320 (derivative) · Grant/award (A): 136,884 (derivative) | EDGAR |
| 2026-06-16 | 4 | Ramasastry Saira — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Faeth Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-17 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-04 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-18 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-15 | 8-K | 1.02 — Termination of a Material Definitive Agreement 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-10 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-22 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-05-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-15 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=FTH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →